Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the ten analysts that are currently covering the company, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $15.77.
SBRA has been the subject of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft began coverage on Sabra Health Care REIT in a report on Tuesday, January 30th. They set a “buy” rating and a $21.00 target price for the company. Wedbush reissued an “outperform” rating and set a $17.00 price objective on shares of Sabra Health Care REIT in a research report on Thursday, February 29th.
Get Our Latest Stock Analysis on SBRA
Hedge Funds Weigh In On Sabra Health Care REIT
Sabra Health Care REIT Stock Up 0.9 %
Shares of NASDAQ:SBRA opened at $14.35 on Friday. The stock’s 50-day moving average is $14.09 and its 200 day moving average is $14.03. The company has a market cap of $3.32 billion, a PE ratio of 287.00, a P/E/G ratio of 5.15 and a beta of 1.17. The company has a debt-to-equity ratio of 0.86, a current ratio of 3.41 and a quick ratio of 3.41. Sabra Health Care REIT has a 1 year low of $10.30 and a 1 year high of $14.91.
About Sabra Health Care REIT
As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.
See Also
- Five stocks we like better than Sabra Health Care REIT
- Stock Splits, Do They Really Impact Investors?
- MarketBeat Week in Review – 4/29 – 5/3
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- 3 Fintech Stocks With Good 2021 Prospects
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.